DelveInsight has launched a new report on “Aortic Stenosis Market Insights, Epidemiology, and Market Forecast-2032”. 

DelveInsight’s “Aortic Stenosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Aortic Stenosis, historical and forecasted epidemiology as well as the Aortic Stenosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Aortic Stenosis Market Report: 

• In the US, Aortic Stenosis is present in about 5% of the population at age 65 with an increasing prevalence with advancing age 
• According to research, the population prevalence of AS of 12.4%, and a prevalence of 3.4% of severe AS in those aged 75 years and older 
• According to a journal, the prevalence in Japan of any valve disease is 2.5%. Of those with valve disease, about 0.4% have aortic stenosis 
• As per the studies, there is a slight predominance of Aortic Stenosis in males than in females 

Request a sample for the Report: https://www.delveinsight.com/sample-request/calcific-aortic-valve-stenosis-cavs-epidemiology-forecast

Key benefits of the report:

1. Aortic Stenosis market report covers a descriptive overview and comprehensive insight of the Aortic Stenosis Epidemiology and Aortic Stenosis  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Aortic Stenosis market report provides insights on the current and emerging therapies.
3. Aortic Stenosis market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Aortic Stenosis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Aortic Stenosis market.

Got queries? Click here to know more about the Aortic Stenosis Market Landscape 

Aortic Stenosis Overview: 

Aortic stenosis is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 years. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years. 

Aortic stenosis has several etiologies, including congenital (unicuspid or bicuspid valve), acquired which includes degenerative calcification, and rheumatic heart disease. Degenerative calcific aortic stenosis is now the leading indication for aortic valve replacement. The favorable long-term outcome following aortic valve surgery and the relatively low operative risk emphasizes the importance of an accurate and timely diagnosis. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years. Exertional dyspnea or fatigue is the most common initial complaint. Ultimately, most patients experience the classic triad of chest pain, heart failure, and syncope. Stages of the condition include asymptomatic and symptomatic stages taking into consideration the valve hemodynamics. 

Aortic Stenosis Symptoms:

The symptoms of Aortic Stenosis include –

• Abnormal heart rates
• Pain in the chest
• Shortness in breathing
• Dizziness
• Body Fatigue

Aortic Stenosis Market  

The dynamics of the Aortic Stenosis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Edoxaban, and others during the forecasted period 2019-2032. 

Learn more by requesting for sample @Aortic Stenosis Market Landscape  

Aortic Stenosis Pipeline Therapies:

• Rosuvastatin
• Bivalirudin
• Edoxaban
• Ataciguat 

Aortic Stenosis Pipeline Key Companies:

• Bayer 
• AstraZeneca
• Ferring Pharmaceuticals 
• Duke Clinical Research 

Table of Contents 

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Aortic Stenosis Patient Share (%) Overview at a Glance

5. Aortic Stenosis Market Overview at a Glance

6. Aortic Stenosis Disease Background and Overview

7. Aortic Stenosis Epidemiology and Patient Population

8. Country-Specific Patient Population of Aortic Stenosis 

9. Aortic Stenosis Current Treatment and Medical Practices

10. Unmet Needs

11. Aortic Stenosis Emerging Therapies

12. Aortic Stenosis Market Outlook

13. Country-Wise Aortic Stenosis Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Aortic Stenosis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight 

To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com